Work

Magnetic hydroxyapatite nanomaterial–cyclodextrin tethered polymer hybrids as anticancer drug carriers

Year: 2021
Type: article
Abstract: Osteosarcoma, the most common bone cancer, leads to a poor survival rate of patients. Drug targeting employing hydroxyapatite (HAp)-based nanocarriers represents a fascinating choice for non-invasive treatment of osteosarcoma.
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $1,962
OpenAlex ID: W3136769917
FWCI: 1.161
Cites: 60
Cited by: 34
Related to: 10